Highlights
- EPS (TTM)
- $15.16
- PE Ratio
- 14.81
- PEG Ratio
- 0.46
- Total Revenue (TTM)
- $5.40B
- Gross Profit (TTM)
- $3.29B
- EBITDA (TTM)
- $1.96B
- Year Range
- $199.92 - $293.81
- Target Price
- $294.00
- ROA (TTM)
- 17.47%
- ROE (TTM)
- 23.51%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in ResMed Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
ResMed Inc. (RMD) has returned -6.59% so far this year and 1.18% over the past 12 months. Looking at the last ten years, RMD has achieved an annualized return of 15.62%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.
ResMed Inc.
- 1D
- 2.02%
- 1M
- -12.40%
- YTD
- -6.59%
- 6M
- -17.61%
- 1Y
- 1.18%
- 3Y*
- 1.78%
- 5Y*
- 3.81%
- 10Y*
- 15.62%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jun 2, 1995, RMD's average daily return is +0.11%, while the average monthly return is +2.17%. At this rate, your investment would double in approximately 2.7 years.
Historically, 61% of months were positive and 39% were negative. The best month was Feb 2000 with a return of +73.5%, while the worst month was Feb 1999 at -37.1%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 4 months.
On a daily basis, RMD closed higher 51% of trading days. The best single day was Apr 14, 1999 with a return of +27.4%, while the worst single day was May 3, 2000 at -22.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 7.24% | -0.56% | -12.40% | -6.59% | |||||||||
| 2025 | 3.28% | -0.90% | -4.14% | 5.69% | 3.69% | 5.40% | 5.40% | 1.16% | -0.28% | -9.81% | 3.87% | -5.85% | 6.26% |
| 2024 | 10.57% | -8.43% | 13.99% | 8.06% | -3.37% | -7.23% | 11.40% | 15.17% | -0.37% | -0.68% | 2.92% | -8.16% | 34.18% |
| 2023 | 9.72% | -6.55% | 2.81% | 10.03% | -12.35% | 3.66% | 1.76% | -28.04% | -7.34% | -4.50% | 12.05% | 9.06% | -16.55% |
| 2022 | -12.24% | 8.13% | -1.72% | -17.54% | 1.96% | 3.03% | 14.74% | -8.39% | -0.74% | 2.47% | 3.12% | -9.59% | -19.47% |
| 2021 | -5.17% | -4.17% | 0.64% | -3.12% | 9.73% | 19.76% | 10.25% | 7.05% | -9.29% | -0.24% | -2.91% | 2.21% | 23.41% |
Benchmark Metrics
ResMed Inc. has an annualized alpha of 21.67%, beta of 0.80, and R² of 0.14 versus S&P 500 Index. Calculated based on daily prices since June 05, 1995.
- This stock captured 132.53% of S&P 500 Index gains but only 74.95% of its losses — a favorable profile for investors.
- R² of 0.14 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 21.67%
- Beta
- 0.80
- R²
- 0.14
- Upside Capture
- 132.53%
- Downside Capture
- 74.95%
Return for Risk
Risk / Return Rank
RMD ranks 40 for risk / return — below 40% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for ResMed Inc. (RMD) and compare them to a chosen benchmark (S&P 500 Index).
| RMD | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.05 | 0.90 | -0.85 |
Sortino ratioReturn per unit of downside risk | 0.26 | 1.39 | -1.13 |
Omega ratioGain probability vs. loss probability | 1.03 | 1.21 | -0.18 |
Calmar ratioReturn relative to maximum drawdown | 0.12 | 1.40 | -1.28 |
Martin ratioReturn relative to average drawdown | 0.28 | 6.61 | -6.32 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore RMD risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
ResMed Inc. provided a 1.04% dividend yield over the last twelve months, with an annual payout of $2.33 per share. The company has been increasing its dividends for 13 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.33 | $2.26 | $2.02 | $1.84 | $1.72 | $1.62 | $1.56 | $1.52 | $1.44 | $1.36 | $1.26 | $1.16 |
Dividend yield | 1.04% | 0.94% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% |
Monthly Dividends
The table displays the monthly dividend distributions for ResMed Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.60 | $0.00 | $0.60 | |||||||||
| 2025 | $0.00 | $0.53 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.60 | $0.00 | $0.00 | $0.60 | $0.00 | $2.26 |
| 2024 | $0.00 | $0.48 | $0.00 | $0.00 | $0.48 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.53 | $0.00 | $2.02 |
| 2023 | $0.00 | $0.44 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.48 | $0.00 | $0.00 | $0.48 | $0.00 | $1.84 |
| 2022 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.44 | $0.00 | $1.72 |
| 2021 | $0.00 | $0.39 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $1.62 |
Dividend Yield & Payout
Dividend Yield
ResMed Inc. has a dividend yield of 1.04%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
ResMed Inc. has a payout ratio of 22.25%, which is below the market average. This means ResMed Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the ResMed Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the ResMed Inc. was 61.61%, occurring on Apr 8, 1999. Recovery took 200 trading sessions.
The current ResMed Inc. drawdown is 23.22%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -61.61% | Jan 26, 1999 | 51 | Apr 8, 1999 | 200 | Jan 21, 2000 | 251 |
| -60% | Dec 4, 2001 | 127 | Jun 6, 2002 | 726 | Apr 25, 2005 | 853 |
| -53.99% | Sep 9, 2021 | 538 | Oct 27, 2023 | 441 | Aug 4, 2025 | 979 |
| -45.02% | Feb 5, 2007 | 437 | Oct 27, 2008 | 321 | Feb 5, 2010 | 758 |
| -44.48% | Mar 23, 2000 | 46 | May 26, 2000 | 146 | Dec 22, 2000 | 192 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of ResMed Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how ResMed Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for RMD, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, RMD has a P/E ratio of 14.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for RMD compared to other companies in the Medical Instruments & Supplies industry. RMD currently has a PEG ratio of 0.5. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for RMD relative to other companies in the Medical Instruments & Supplies industry. Currently, RMD has a P/S ratio of 4.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |